Literature DB >> 28233119

Association between interleukin-6 and the risk of cardiac events measured by coronary computed tomography angiography.

Lei Zhao1, Xilin Wang2, Yuhai Yang3.   

Abstract

Interleukin-6 (IL-6) has been found to be a predictor of heart attack. We aimed to investigate the relationship of risk factor IL-6 with extent and severity of the coronary artery disease (CAD) evaluated using coronary computed tomography angiography (CCTA). A total of 303 participants without history of CAD undergoing CCTA were enrolled. Using the model of risk-adjusted Cox proportional-hazards, the association of IL-6 level with major adverse cardiac events (MACE) was detected. The participants were assigned into three study groups based on serum IL-6 level. Compared with those in the lowest tertile, patients with highest IL-6 level displayed higher atherosclerotic burden such as plaque extent defined as prevalence of obstructive CAD and segments with any plaque. After a median 3.0 year follow-up period, we also found that patients with highest IL-6 level experienced higher MACE risk and all-cause death compared with those from the lowest tertile. Among participants without CAD history who underwent CCTA, patients with high level of IL-6 had increased burden of atherosclerosis and higher MACE risk compared to participants of low level of IL-6.

Entities:  

Keywords:  Coronary artery disease; Coronary computed tomography angiography; Heart attack; IL-6; Plaque

Mesh:

Substances:

Year:  2017        PMID: 28233119     DOI: 10.1007/s10554-017-1098-y

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  32 in total

1.  The associations of interleukin-6 (IL-6) and downstream inflammatory markers with risk of cardiovascular disease: the Caerphilly Study.

Authors:  Christopher C Patterson; Anne E Smith; John W G Yarnell; Ann Rumley; Yoav Ben-Shlomo; Gordon D O Lowe
Journal:  Atherosclerosis       Date:  2009-09-27       Impact factor: 5.162

2.  TNFalpha antagonist upregulates interleukin-6 in rats with hypertensive heart failure.

Authors:  Espen Haugen; Margareta Scharin Täng; Azra Isic; Bert Andersson; Michael Fu
Journal:  Int J Cardiol       Date:  2008-02-15       Impact factor: 4.164

3.  Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study.

Authors:  Brenda W J H Penninx; Stephen B Kritchevsky; Kristine Yaffe; Anne B Newman; Eleanor M Simonsick; Susan Rubin; Luigi Ferrucci; Tamara Harris; Marco Pahor
Journal:  Biol Psychiatry       Date:  2003-09-01       Impact factor: 13.382

4.  Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition [Health ABC] Study).

Authors:  Matteo Cesari; Brenda W J H Penninx; Anne B Newman; Stephen B Kritchevsky; Barbara J Nicklas; Kim Sutton-Tyrrell; Russell P Tracy; Susan M Rubin; Tamara B Harris; Marco Pahor
Journal:  Am J Cardiol       Date:  2003-09-01       Impact factor: 2.778

5.  Increased interleukin-6 but not tumour necrosis factor-alpha predicts mortality in the population of elderly heart failure patients.

Authors:  Espen Haugen; Li-Ming Gan; Azra Isic; Tomas Skommevik; Michael Fu
Journal:  Exp Clin Cardiol       Date:  2008

6.  Prognostic value of multidetector coronary computed tomographic angiography for prediction of all-cause mortality.

Authors:  James K Min; Leslee J Shaw; Richard B Devereux; Peter M Okin; Jonathan W Weinsaft; Donald J Russo; Nicholas J Lippolis; Daniel S Berman; Tracy Q Callister
Journal:  J Am Coll Cardiol       Date:  2007-09-04       Impact factor: 24.094

7.  Association between serum interleukin-6 concentrations and mortality in older adults: the Rancho Bernardo study.

Authors:  Jeffrey K Lee; Ricki Bettencourt; David Brenner; Thuy-Anh Le; Elizabeth Barrett-Connor; Rohit Loomba
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

8.  The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis.

Authors:  Daniel I Swerdlow; Michael V Holmes; Karoline B Kuchenbaecker; Jorgen E L Engmann; Tina Shah; Reecha Sofat; Yiran Guo; Christina Chung; Anne Peasey; Roman Pfister; Simon P Mooijaart; Helen A Ireland; Maarten Leusink; Claudia Langenberg; Ka Wah Li; Jutta Palmen; Philip Howard; Jackie A Cooper; Fotios Drenos; John Hardy; Michael A Nalls; Yun Rose Li; Gordon Lowe; Marlene Stewart; Suzette J Bielinski; Julian Peto; Nicholas J Timpson; John Gallacher; Malcolm Dunlop; Richard Houlston; Ian Tomlinson; Ioanna Tzoulaki; Jian'an Luan; Jolanda M A Boer; Nita G Forouhi; N Charlotte Onland-Moret; Yvonne T van der Schouw; Renate B Schnabel; Jaroslav A Hubacek; Ruzena Kubinova; Migle Baceviciene; Abdonas Tamosiunas; Andrzej Pajak; Roman Topor-Madry; Sofia Malyutina; Damiano Baldassarre; Bengt Sennblad; Elena Tremoli; Ulf de Faire; Luigi Ferrucci; Stefania Bandenelli; Toshiko Tanaka; James F Meschia; Andrew Singleton; Gerjan Navis; Irene Mateo Leach; Stephan J L Bakker; Ron T Gansevoort; Ian Ford; Stephen E Epstein; Mary Susan Burnett; Joe M Devaney; J Wouter Jukema; Rudi G J Westendorp; Gert Jan de Borst; Yolanda van der Graaf; Pim A de Jong; Anke-Hilse Mailand-van der Zee; Olaf H Klungel; Anthonius de Boer; Pieter A Doevendans; Jeffrey W Stephens; Charles B Eaton; Jennifer G Robinson; JoAnn E Manson; F Gerry Fowkes; Timonthy M Frayling; Jackie F Price; Peter H Whincup; Richard W Morris; Debbie A Lawlor; George Davey Smith; Yoav Ben-Shlomo; Susan Redline; Leslie A Lange; Meena Kumari; Nick J Wareham; W M Monique Verschuren; Emelia J Benjamin; John C Whittaker; Anders Hamsten; Frank Dudbridge; J A Chris Delaney; Andrew Wong; Diana Kuh; Rebecca Hardy; Berta Almoguera Castillo; John J Connolly; Pim van der Harst; Eric J Brunner; Michael G Marmot; Christina L Wassel; Steve E Humphries; Philippa J Talmud; Mika Kivimaki; Folkert W Asselbergs; Mikhail Voevoda; Martin Bobak; Hynek Pikhart; James G Wilson; Hakon Hakonarson; Alex P Reiner; Brendan J Keating; Naveed Sattar; Aroon D Hingorani; Juan Pablo Casas
Journal:  Lancet       Date:  2012-03-14       Impact factor: 79.321

9.  Analysis of the role of interleukin 6 receptor haplotypes in the regulation of circulating levels of inflammatory biomarkers and risk of coronary heart disease.

Authors:  Bruna Gigante; Rona J Strawbridge; Ilais Moreno Velasquez; Zahra Golabkesh; Angela Silveira; Anuj Goel; Damiano Baldassarre; Fabrizio Veglia; Elena Tremoli; Robert Clarke; Hugh Watkins; Anders Hamsten; Steve E Humphries; Ulf de Faire
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

10.  Hypomethylation of Interleukin-6 Promoter is Associated with the Risk of Coronary Heart Disease.

Authors:  Hong-Peng Zuo; Ying-Yu Guo; Lin Che; Xian-Zheng Wu
Journal:  Arq Bras Cardiol       Date:  2016-08       Impact factor: 2.000

View more
  5 in total

1.  Coronary Atherosclerosis, Cardiac Troponin, and Interleukin-6 in Patients With Chest Pain: The PROMISE Trial Results.

Authors:  Maros Ferencik; Thomas Mayrhofer; Michael T Lu; Daniel O Bittner; Hamed Emami; Stefan B Puchner; Nandini M Meyersohn; Alexander V Ivanov; Elizabeth C Adami; Deepak Voora; Geoffrey S Ginsburg; James L Januzzi; Pamela S Douglas; Udo Hoffmann
Journal:  JACC Cardiovasc Imaging       Date:  2022-05-11

2.  Acute Changes in Interleukin-6 Level During Four Days of Long-Distance Walking.

Authors:  Viviane Soares; Ivan Silveira de Avelar; Patrícia Espíndola Mota Venâncio; Deise A A Pires-Oliveira; Pedro Henrique de Almeida Silva; Amanda Rodrigues Borges; Gustavo Paz Estevez Ferreira Fonseca; Matias Noll
Journal:  J Inflamm Res       Date:  2020-11-10

3.  Coronary computed tomography angiography detection of short- and long-term outcomes after heart valve surgery with high risk cardiovascular patients.

Authors:  Zhi Zhu; Shuofeng Li
Journal:  Biosci Rep       Date:  2018-03-09       Impact factor: 3.840

Review 4.  Sudden Cardiac Death (SCD) - risk stratification and prediction with molecular biomarkers.

Authors:  Junaida Osman; Shing Cheng Tan; Pey Yee Lee; Teck Yew Low; Rahman Jamal
Journal:  J Biomed Sci       Date:  2019-05-22       Impact factor: 12.771

5.  Increased glycoprotein acetylation is associated with high cardiac event rates: Analysis using coronary computed tomography angiography.

Authors:  Lihua An; Qingxu Liu; Haixia Feng; Xueqin Bai; Yan Dang; Chao Li; Zili Yang; Jing Li
Journal:  Anatol J Cardiol       Date:  2018-09       Impact factor: 1.596

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.